21496/34348US=23-A / Câncer
Hayat MA. Lung carcinoma. In: ___. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 203-6. ISBN 978-1-4020-8441-62.

CANCER; CARCINOMA DO PULMAO

21497/34348US=2 / Tórax
Hanrahan EO, Nilsson M, Heymach JV. Tumor angiogenesis: biology and therapeutic implications for lung cancer. In: Roth JA, Cox JD, Hong WK, editors. Lung cancer. 3rd ed. Oxford: Blackwell Science, 2008. p. 369-85. ISBN 978-1-4051-5112-2.

ANGIOGENESE TUMORAL; TERAPEUTICA PARA O CANCER DE PULMAO; ANGIOGENESE NO CANCER DE PULMAO

21498/34348US=23-A / Câncer
Shahid RK, Haider K, Sami A, Imran A, Arnold F, Yadav S, Harding K, Brigden M, Popkin D, Ahmed S. Extra-pulmonary small cell cancer: diagnosis, treatment, and prognosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 207-17. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PEQUENAS CELULAS EXTRA-PULMONAR; DIAGNOSTICO; TRATAMENTO; PROGNOSTICO; CARCINOMA DE PEQUENAS CELULAS. EPIDEMIOLOGIA; CARCINOMA DE PEQUENAS CELULAS. DIAGNOSTICO; CARCINOMA DE PEQUENAS CELULAS. TRATAMENTO; CARCINOMA DE PEQUENAS CELULAS. PROGNOSTICO; TRATO GENITOURINARIO; TRATO GASTROINTESTINAL; CABECA E PESCOCO; MAMA

21499/34348US=23-A / Câncer
Sensakovic WF, Armato III SG. Magnetic resonance imaging of the lung: automated segmentation methods. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 219-34. ISBN 978-1-4020-8441-62.

CANCER; PULMAO; RESSONANCIA MAGNETICA; SEGMENTACAO AUTOMATICA. METODOS; RESSONANCIA MAGNETICA TORACICA; METODOS DE SEGMENTACAO AUTOMATIZADA; OPERADORES DE LIMIARIZACAO; DESCRITORES DE FORMA; PARAMETRICOS CONTORNOS ATIVOS; REDE NEURAL; COMBINACAO CONTORNO ATIVO

21500/34348US=35 / Estatística
Boscoe FP. The science and art of geocoding: tips for improvig match rates and handling unmatched cases in analysis. In: Rushton G, Armstrong MP, Gittler J, Greene BR, Pavlik CE, West MM, Zimmerman DL. Geocoding health data: the use of geographic codes in cancer prevention and control research and practice. New York: Taylor & Francis, 2008. p. 95-109. ISBN 0-8493-8419-2.

CIENCIA EA ARTE DE GEOCODIFICACAO; TAXAS DE FOSFORO; TRATAMENTO DE CASOS INCOMPARAVEL EM ANALISE

21501/34348US=2 / Tórax
Bhadkamkar NA, Khuri FR. Retinoids and rexinoids in lung cancer prevention and treatment. In: Roth JA, Cox JD, Hong WK, editors. Lung cancer. 3rd ed. Oxford: Blackwell Science, 2008. p. 386-98. ISBN 978-1-4051-5112-2.

RETINOIDES; REXINOIDES; CANCER DE PULMAO. PREVENCAO; CANCER DE PULMAO. TRATAMENTO

21502/34348US=2 / Tórax
Huynh M, Lara PN Jr. Proteasome inhibition in nonsmall cell lung cancer therapy. In: Roth JA, Cox JD, Hong WK, editors. Lung cancer. 3rd ed. Oxford: Blackwell Science, 2008. p. 400-10. ISBN 978-1-4051-5112-2.

INIBICAO DO PROTEASSOMA EM NAO PEQUENA; TERAPIA DE CANCER DE PULMAO DE CELULAS

21503/34348US=23-A / Câncer
Gorg C, Holland A. Peripheral lung lesions: diagnosis using transcutaneous contrast-enhanced sonography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 235-45. ISBN 978-1-4020-8441-62.

CANCER; LESOES PULMONARES PERIFERICAS; ULTRA-SONOGRAFIA TRANSCUTANEA; VASCULARIZACAO PULMONAR; ULTRA-SONOGRAFIA COM CONTRASTE

21504/34348US=35 / Estatística
Abe T, Stinchcomb D. Geocoding practices in cancer registries. In: Rushton G, Armstrong MP, Gittler J, Greene BR, Pavlik CE, West MM, Zimmerman DL. Geocoding health data: the use of geographic codes in cancer prevention and control research and practice. New York: Taylor & Francis, 2008. p. 111-25. ISBN 0-8493-8419-2.

PRATICAS DE GEOCODIFICACAO EM REGISTROS DE CANCER; CANCER DE DADOS DO REGISTRO PADROES DE ENDERECO; PRATICAS DE GEOCODIFICACAO

21505/34348US=35 / Estatística
Zimmerman DL, Armstrong MP, Rushton G. Alternative techniques for masking geographic detail to protect privacy. In: Rushton G, Armstrong MP, Gittler J, Greene BR, Pavlik CE, West MM, Zimmerman DL. Geocoding health data: the use of geographic codes in cancer prevention and control research and practice. New York: Taylor & Francis, 2008. p. 127-38. ISBN 0-8493-8419-2.

TECNICAS ALTERNATIVAS PARA MASCARAR DETALHE GEOGRAFICO; SISTEMA DE INFORMACAO GEOGRAFICA; ABORDAGENS GEOGRAFICAS MASCARAMENTO; PRESERVACAO DE INFORMACOES

21506/34348US=23-A / Câncer
Das M. Small pulmonary nodules: detection using multidetector-row computed tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 247-60. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; NODULOS PULMONARES; TOMOGRAFIA COMPUTADORIZADA; GRANULOMA; HARMATOMA; METASTASE

21507/34348US=23-A / Câncer
Takigawa N, Segawa Y, Kiura K. Secondary primary cancer following chemoradiation for non-small-cell lung cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 261-7. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; QUIMIORRADIACAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS

21508/34348US=23-A / Câncer
Gridelli C, Maione P. Advanced non-small cell lung cancer: second-line treatment with docetaxel. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 269-80. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; DOCETAXEL; TRATAMENTO

21509/34348US=23-A / Câncer
Nelli F, Moscetti L. Non-small cell lung cancer with brain metastases: platinum-based chemotherapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 281-9. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; METASTASES CEREBRAIS; QUIMIOTERAPIA; PLATINA

21510/34348US=23-A / Câncer
Bartolazzi A. Non-small cell lung carcinoma: EGFR gene mutations and response to gefitinib. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 291-306. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; MUTACOES EGFR; GEFITINIBE; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO

21511/34348US=23-A / Câncer
Kiura K, Takigawa N, Segawa Y. Advanced non-small cell lung carcinoma: acquired resistance to gefitinib. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 307-16. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; CARCINOMA NAO PEQUENAS CELULAS DO PULMAO AVANCADA; RESISTENCIA A GEFITINIBE; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO

21512/34348US=23-A / Câncer
Nomori H. Prognostic significance of [18F]-Fluorodeoxyglucose uptake on positron emission tomography in patients with pathological stage I lung adenocarcinoma. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 317-22. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; PROGNOSTICO; [18F]-FLUORODEOXIGLICOSE; TOMOGRAFIA POR EMISSAO DE POSITRONS; ESTADIO PATOLOGICO I; ADENOCARCINOMA DE PULMAO

21513/34348US=23-A / Câncer
Pfannschmidt J, Bulzebruck H, Dienemann H. Non-small cell lung cancer: prognosis using the TNM staging system. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 323-36. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE CELULAS NAO-PEQUENAS; PROGNOSTICO; SISTEMA TNM; CLASSIFICACAO DE TUMORES MALIGNOS

21514/34348US=23-A / Câncer
Benlloch S, Galbis-Caravajal JM, Massutí B. Differentiation between malignant and benign pleural effusions: methylation specific polymerase chain reaction analysis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 337-47. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; DERRAME PLEURAL MALIGNO; DERRAME PLEURAL BENIGNO; METILACAO; POLIMERASE; REACAO EM CADEIA

21515/34348US=23-A / Câncer
Hiroshima K. Pathological distinction of pulmonary large cell neuroendocrine carcinoma from small-cell lung carcinoma using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 349-61. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; CARCINOMA PULMONAR DE CELULAS GRANDES; CARCINOMA DE PULMAO DE PEQUENAS CELULAS; IMUNOHISTOQUIMICA; CARCINOMA DE GRANDES CELULAS NEUROENDOCRINO; MORFOMETRIA; BIOLOGIA MOLECULAR

Primeira | Anterior | Próxima | Última